Trials / Recruiting
RecruitingNCT05264259
New Therapeutic Approach Against BK Virus Infection Based on Monoclonal Antibodies
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- University Hospital, Strasbourg, France · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
BK virus (BKV) infection has a major negative impact on transplant recipients. No BKV-specific antiviral therapy is available, so there is an urgent need to develop new anti-BKV preventive and therapeutic strategies.
Conditions
Timeline
- Start date
- 2022-09-05
- Primary completion
- 2022-09-05
- Completion
- 2025-12-01
- First posted
- 2022-03-03
- Last updated
- 2025-08-08
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05264259. Inclusion in this directory is not an endorsement.